We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$461B
AUM Growth
+$24.9B
Cap. Flow
-$12.1B
Cap. Flow %
-2.62%
Top 10 Hldgs %
40.03%
Holding
5,800
New
615
Increased
1,596
Reduced
2,751
Closed
340

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.34B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.65B
3
TSLA icon
Tesla
TSLA
+$1.45B
4
QQQ icon
Invesco QQQ Trust
QQQ
+$1.01B
5
AAPL icon
Apple
AAPL
+$833M

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Financials 7.27%
3 Consumer Discretionary 6.82%
4 Communication Services 5.06%
5 Healthcare 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRVO icon
5276
CervoMed
CRVO
$23M
$8 ﹤0.01%
1
-416
-100% -$3.57K
GTIM icon
5277
Good Times Restaurants
GTIM
$14.9M
$8 ﹤0.01%
+5
New +$8
MNTS icon
5278
Momentus
MNTS
$78.4M
0
ONL
5279
Orion Office REIT
ONL
$151M
$8 ﹤0.01%
3
ATNM icon
5280
Actinium Pharmaceuticals
ATNM
$26.3M
$7 ﹤0.01%
4
-2,504
-100% -$4.08K
FTCI icon
5281
FTC Solar
FTCI
$41.6M
$7 ﹤0.01%
1
JOB icon
5282
GEE Group
JOB
$22.8M
$7 ﹤0.01%
+33
New +$7
MGX icon
5283
Metagenomi Therapeutics
MGX
$45.6M
$7 ﹤0.01%
3
NRGV icon
5284
Energy Vault
NRGV
$455M
$6 ﹤0.01%
2
-14,256
-100% -$23.4K
AMTX icon
5285
Aemetis
AMTX
$99.2M
$5 ﹤0.01%
2
-3,964
-100% -$10.5K
PRHI
5286
Presurance Holdings
PRHI
$19.4M
$5 ﹤0.01%
+1
New +$7
LGHL
5287
Lion Group Holding
LGHL
$997K
0
XTNT icon
5288
Xtant Medical Holdings
XTNT
$59.8M
$5 ﹤0.01%
+8
New +$5
ASRT
5289
DELISTED
Assertio
ASRT
0
KZR
5290
DELISTED
Kezar Life Sciences
KZR
$4 ﹤0.01%
1
UP icon
5291
Wheels Up
UP
$203M
-181
Closed -$6.6K
VRCA icon
5292
Verrica Pharmaceuticals
VRCA
$89M
$4 ﹤0.01%
1
-1
-50% -$6
VTGN icon
5293
VistaGen Therapeutics
VTGN
$9.98M
$4 ﹤0.01%
1
ACHV icon
5294
Achieve Life Sciences
ACHV
$633M
$3 ﹤0.01%
1
-1,715
-100% -$4.71K
CBUS icon
5295
Cibus
CBUS
$148M
$3 ﹤0.01%
2
FLL icon
5296
Full House Resorts
FLL
$83.4M
$3 ﹤0.01%
1
MBOT icon
5297
Microbot Medical
MBOT
$112M
$3 ﹤0.01%
1
MODV
5298
DELISTED
ModivCare
MODV
$3 ﹤0.01%
14
TELO icon
5299
Telomir Pharmaceuticals
TELO
$83.2M
$3 ﹤0.01%
2
-3,015
-100% -$4.55K
GCTS
5300
GCT Semiconductor Holding
GCTS
$158M
$3 ﹤0.01%
2
-62
-97% -$88

Similar funds

Barclays's Q3 2025 Portfolio in Review

As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
  • Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
  • Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
  • Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
  • Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
  • Barclays opened 615 new positions and closed 340 in Q3 2025.
  • Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.